(Q35701625)

9 August 2017

1 reference

title

Can better prescribing turn the tide of resistance? (English)

1 reference

9 August 2017

David Livermore

1

1 reference

PubMed ID

15035011

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Nature Reviews Microbiology

9 August 2017

1 reference

9 August 2017

2

1 reference

9 August 2017

1

1 reference

9 August 2017

73-78

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro798

9 August 2017

0 references

cites work

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Bacterial resistance: origins, epidemiology, and impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Antibiotic resistance--squeezing the balloon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Antibiotic resistance in the absence of selective pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Evolution of a bacteria/plasmid association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Why is big Pharma getting out of antibacterial drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

The role of mutators in the emergence of antibiotic-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

CTX-M extended-spectrum beta-lactamase arrives in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Effective antibiotic-resistance control strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Staphylococcus aureus carrier state among elderly residents of a long-term care facility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Proteic toxin-antitoxin, bacterial plasmid addiction systems and their evolution with special reference to the pas system of pTF-FC2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

TEM-24 extended-spectrum beta-lactamase-producing Enterobacter aerogenes: long-term clonal dissemination in French hospitals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

The threat from the pink corner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Antibiotic clinical trials revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Resistance to antibiotics mediated by target alterations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO798

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRMICRO798

1 reference

9 August 2017

1 reference

PubMed ID

15035011